161 related articles for article (PubMed ID: 36255482)
1. Case series of chronic spontaneous urticaria following COVID-19 vaccines: an unusual skin manifestation.
Ben-Fredj N; Chahed F; Ben-Fadhel N; Mansour K; Ben-Romdhane H; Mabrouk RSE; Chadli Z; Ghedira D; Belhadjali H; Chaabane A; Aouam K
Eur J Clin Pharmacol; 2022 Dec; 78(12):1959-1964. PubMed ID: 36255482
[TBL] [Abstract][Full Text] [Related]
2. Relapse or worsening of chronic spontaneous urticaria during SARS-CoV-2 infection and vaccination in children: A telemedicine follow-up.
Lascialfari G; Sarti L; Barni S; Liccioli G; Paladini E; Guarnieri V; Ricci S; Giovannini M; Mori F
Allergol Immunopathol (Madr); 2022; 50(S Pt 2):1-7. PubMed ID: 36156167
[TBL] [Abstract][Full Text] [Related]
3. Delayed systemic urticarial reactions following mRNA COVID-19 vaccination.
Pitlick MM; Joshi AY; Gonzalez-Estrada A; Chiarella SE
Allergy Asthma Proc; 2022 Jan; 43(1):40-43. PubMed ID: 34983709
[No Abstract] [Full Text] [Related]
4. Chronic Spontaneous Urticaria Following mRNA COVID-19 Booster Vaccination at a Military Academy.
Miller MA; Raffetto ER; Lee RU
Mil Med; 2024 Feb; 189(3-4):e911-e914. PubMed ID: 37725042
[TBL] [Abstract][Full Text] [Related]
5. Urticaria relapse after mRNA COVID-19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single-center experience.
Picone V; Napolitano M; Martora F; Guerriero L; Fabbrocini G; Patruno C
Dermatol Ther; 2022 Nov; 35(11):e15838. PubMed ID: 36109351
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of immune response profile in patients with immediate allergic and autoimmune urticarial reactions induced by SARS-CoV-2 vaccines.
Wang CW; Chen CB; Lu CW; Chen WT; Hui RC; Chiu TM; Chi MH; Lin JC; Huang YH; Chang YC; Wu J; Chen KY; Lin YY; Ger TY; Lin JY; Tsai WT; Pan YJ; Chung WH
J Autoimmun; 2023 Jul; 138():103054. PubMed ID: 37245259
[TBL] [Abstract][Full Text] [Related]
7. New-onset chronic spontaneous urticaria post-COVID-19 vaccination-South African case series.
Craffert V; Day C; Peter J
J Allergy Clin Immunol Glob; 2023 Nov; 2(4):100154. PubMed ID: 37781658
[TBL] [Abstract][Full Text] [Related]
8. Exacerbation of Chronic Spontaneous Urticaria Following Coronavirus Disease 2019 (COVID-19) Vaccination in Omalizumab-Treated Patients.
Lee JH; Shin E; Kim HK; Song WJ; Kwon HS; Kim TB; Cho YS
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2403-2410. PubMed ID: 37182571
[TBL] [Abstract][Full Text] [Related]
9. H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.
Maurer M; Staubach P; Raap U; Richter-Huhn G; Bauer A; Ruëff F; Jakob T; Yazdi AS; Mahler V; Wagner N; Lippert U; Hillen U; Schwinn A; Pawlak M; Behnke N; Chaouche K; Chapman-Rothe N
Clin Exp Allergy; 2017 May; 47(5):684-692. PubMed ID: 28160338
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of uncontrolled symptoms using the standard dose of second-generation H1 -antihistamines in chronic spontaneous urticaria children.
Koosakulchai V; Yuenyongviwat A; Sangsupawanich P
Asian Pac J Allergy Immunol; 2022 Jun; 40(2):121-125. PubMed ID: 32061244
[TBL] [Abstract][Full Text] [Related]
11. Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study.
Kocatürk E; Salameh P; Sarac E; Vera Ayala CE; Thomsen SF; Zuberbier T; Ensina LF; Popov TA; van Doorn MBA; Giménez-Arnau AM; Asero R; Criado PR; Aarestrup FM; AbdulHameed Ansari Z; Al Abri S; Al-Ahmad M; Al Hinai B; Allenova A; Al-Nesf M; Altrichter S; Arnaout R; Bartosińska J; Bauer A; Bernstein JA; Bizjak M; Bonnekoh H; Bouillet L; Brzoza Z; Calvalcanti Dela Bianca Melo AC; Campinhos FL; Carne E; Purayil SC; Cherrez-Ojeda I; Chong-Neto HJ; Christoff G; Conlon N; Jardim Criado RF; Cvenkel K; Damadoglu E; Danilycheva I; Day C; de Montjoye L; Demir S; Ferucci SM; Fomina D; Fukunaga A; Garcia E; Gelincik A; Göbel JH; Godse K; Gonçalo M; Gotua M; Grattan C; Gugala A; Guillet C; Kalyoncu AF; Karakaya G; Kasperska-Zając A; Katelaris CH; Khoshkhui M; Kleinheinz A; Kolacinska-Flont M; Kolkhir P; Košnik M; Krasowska D; Kumaran MS; Kuprys-Lipinska I; Kurowski M; Kuznetsova EV; Larenas-Linnemann D; Lebedkina MS; Lee Y; Makris M; Gómez RM; Nasr I; Neisinger S; Oda Y; Kara RÖ; Palitot EB; Papapostolou N; Salvador Parisi CA; Pesque D; Peter J; Petkova E; Ridge K; Rudenko M; Rutkowski K; Saini SS; Salman A; Sanchez J; Şekerel B; Serdotetskova SA; Serpa FS; Dikicier BS; Sidiropoulos N; Sikora A; Sørensen JA; Soria A; Kucuk OS; Thalappil SR; Tomaszewska K; Tuncay G; Unal D; Valle S; van Lindonk E; Vestergaard C; Meshkova RY; Vitchuk A; Xepapadaki P; Ye YM; Zalewska-Janowska A; Zamlynski M; Maurer M
J Allergy Clin Immunol; 2023 Nov; 152(5):1095-1106. PubMed ID: 37574079
[TBL] [Abstract][Full Text] [Related]
12. The role of lymphocyte transformation tests (LTT) in suspected severe delayed hypersensitivity reactions following COVID-19 vaccination.
Weir C; Sung-In Jang H; Fernando SL
Hum Vaccin Immunother; 2023 Dec; 19(1):2182527. PubMed ID: 36912718
[TBL] [Abstract][Full Text] [Related]
13. Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2.
Magen E; Yakov A; Green I; Israel A; Vinker S; Merzon E
Allergy Asthma Proc; 2022 Jan; 43(1):30-36. PubMed ID: 34983707
[No Abstract] [Full Text] [Related]
14. Cutaneous reactions after COVID-19 vaccination in Turkey: A multicenter study.
Cebeci Kahraman F; Savaş Erdoğan S; Aktaş ND; Albayrak H; Türkmen D; Borlu M; Arıca DA; Demirbaş A; Akbayrak A; Polat Ekinci A; Gökçek GE; Çelik HA; Taşolar MK; An İ; Temiz SA; Hazinedar E; Ayhan E; Hızlı P; Solak EÖ; Kılıç A; Yılmaz E
J Cosmet Dermatol; 2022 Sep; 21(9):3692-3703. PubMed ID: 35780311
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial.
Fukunaga A; Oda Y; Washio K; Omori T; Kakei Y; Hide M; Nishigori C
Trials; 2020 Jan; 21(1):23. PubMed ID: 31906999
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous adverse events following COVID-19 vaccination: A case series of 30 Japanese patients and a review of 93 Japanese studies.
Baba A; Yamada K; Kanekura T
J Dermatol; 2024 Jun; 51(6):827-838. PubMed ID: 38605482
[TBL] [Abstract][Full Text] [Related]
17. Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study.
Maurer M; Costa C; Gimenez Arnau A; Guillet G; Labrador-Horrillo M; Lapeere H; Meshkova R; Savic S; Chapman-Rothe N
Clin Exp Allergy; 2020 Oct; 50(10):1166-1175. PubMed ID: 32735720
[TBL] [Abstract][Full Text] [Related]
18. Antihistamine-resistant chronic spontaneous urticaria: 1-year data from the AWARE study.
Maurer M; Raap U; Staubach P; Richter-Huhn G; Bauer A; Oppel EM; Hillen U; Baeumer D; Reinhardt M; Chapman-Rothe N
Clin Exp Allergy; 2019 May; 49(5):655-662. PubMed ID: 30415478
[TBL] [Abstract][Full Text] [Related]
19. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
Beckley M; Olson AK; Portman MA
JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
[TBL] [Abstract][Full Text] [Related]
20. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
